An estimated 5 million women in the United States live with a clinical paradox: they have a common hormone disorder called polycystic ovary syndrome, but many don't have ovarian cysts. The obvious discrepancy is just one of the reasons why an independent panel convened by the National Institutes of Health (NIH) concluded that the syndrome's name is too confusing, and it hinders progress in research and effective patient care.
“We believe it is time to assign a name that reflects the complex metabolic, hypothalamic, pituitary, ovarian, and adrenal interactions to characterize polycystic ovary syndrome,” said panel member Robert Rizza, MD, a professor of medicine at the Mayo Clinic in Rochester, Minn.
Graphic Jump Location
Experts recommend changing the name of polycystic ovary syndrome, which has many potential symptoms, and doing more research to improve diagnosis and treatment.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 2
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.